Know Cancer

or
forgot password
  • cancer clinical trials in oakland, CA

  • Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
    Children's Hospital and Research Center Oakland
    Oakland, California 94609
    Neoplastic Syndrome, Non-melanomatous Skin Cancer
    Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    Kaiser Permanente Medical Group/Oakland Medical Center
    Oakland, California 94601
    Myelogenous Leukemia
    Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
    Children's Hospital & Research Center at Oakland
    Oakland, California 94609
    Anemia, Sickle Cell
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840201
    Oakland, California 94611
    Colorectal Neoplasms, Neoplasm Metastasis
    Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase
    Pediatric Clinical Research Center, Children's Hospital Oakland
    Oakland, California 94609
    Hunter Syndrome, Mucopolysaccharidosis II
    Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
    Oakland's Children's Hospital
    Oakland, California 94609
    Osteosarcoma, Leukemia, Lymphoma
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    Children's Hospital and Research Center at Oakland
    Oakland, California 94609-1809
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
    Kaiser Permanente-Oakland
    Oakland, California 94611
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Brain Tumor, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma
    Cognition in the Study of Tamoxifen and Raloxifene
    Kaiser Permanente Division of Research
    Oakland, California 94612
    Cognition, Aging
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    Alameda County Medical Center
    Oakland, California 94602
    HIV Infection
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Children's Hospital and Research Center Oakland
    Oakland, California 94609
    Sarcoma
    Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
    Children's Hospital Oakland Research Institute
    Oakland, California 94609-1693
    Neoplastic Syndrome, Non-melanomatous Skin Cancer
    Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease
    Children's Hospital and Research Center at Oakland
    Oakland, California 94609-1809
    Sickle Cell Disease
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    Children's Hospital and Research Center
    Oakland, California 94609
    Transfusional Hemosiderosis
    Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
    Children's Hospital & Research Center at Oakland
    Oakland, California 94609
    Anemia, Sickle Cell
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    CCOP - Bay Area Tumor Institute

    Trial Locations
    CCOP - Bay Area Tumor Institute
    Highland General Hospital
    Larry G Strieff MD Medical Corporation
    Tom K Lee, Incorporated
    Bay Area Breast Surgeons, Incorporated
    Breast Cancer
    Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
    Oakland Children's Hospital
    Oakland, California
    Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase
    A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
    Childrens Hospital Oakland Research Institute
    Oakland, California 94609
    Basal Cell Carcinoma
    Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).
    Children's Hospital & Research Center at Oakland
    Oakland, California 94609
    Sickle Cell Disease
    Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
    Northern California Hematology & Oncology
    Oakland, California 94609
    Lung Neoplasms, Carcinoma, Cancer of the Lung, Non-Small-Cell Lung Carcinoma
    Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
    Oakland Children's Hospital
    Oakland, California
    Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute
    MsFLASH02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation
    Kaiser Division of Research
    Oakland, California 94611
    Hot Flashes, Menopause, Vasomotor Symptoms
    EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
    Oakland Children's Hospital
    Oakland, California
    Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, T Cell, Leukemia, Lymphoblastic, Acute
    FLU-FIT Program at Kaiser Permanente Northern California
    Kaiser Permanente Northern California
    Oakland, California 94612
    Colorectal Cancer Screening
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    CCOP - Bay Area Tumor Institute

    Trial Locations
    CCOP - Bay Area Tumor Institute
    Larry G Strieff MD Medical Corporation
    Tom K Lee, Incorporated
    Bay Area Breast Surgeons, Incorporated
    Breast Cancer
    A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    Oakland Children's Hospital
    Oakland, California
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood
    Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer
    Children's Hospital Research Center Oakland
    Oakland, California 94609
    Basal Cell Carcinomas
    A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
    Oakland Children's Hospital
    Oakland, California
    Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Peripheral T-cell Lymphoma
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Children's Hospital and Research Center at Oakland
    Oakland, California 94609-1809
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
    Children's Hospital Oakland
    Oakland, California 94609
    Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas
    Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas
    Children's Hospital Oakland
    Oakland, California 94609
    Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
    A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
    Oakland Children's Hospital
    Oakland, California
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood